USPTO serial 79221044
TRANSCON
Reviewed by CopyMark Law Group
Reg. 5881763Status 707Registered
- Filing date
- Status date
- Registration date
- Oct 15, 2019
- Examiner
- PAPALE, LISA ANNE
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with TRANSCON?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Shannon Marie McKeon
Shannon Marie McKeon Dykema Gossett PLLC1301 K Str., N.W., Suite 1100Washington, DC 20005United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Pharmaceutical and veterinary preparations, namely, a drug delivery system in the form of polymer based prodrug formulations which allow for the controlled or continuous release of a wide variety of therapeutic agents for the treatment of mental illness and physical illness in the nature of disorder of the endocrine system, growth hormone deficiency, hypoparathyroidism, achondroplasia, diabetes, fibroblast growth factor receptor (FGFR)-related skeletal disorders, oncology, ophthalmology, infectious disease, enzyme replacement therapy, anti-inflammatory disease, pain, respiratory system disorder, autoimmune disorders, vaccines, non-alcoholic steatohepatitis, brain diseases, bone diseases, CNS diseases, myopathies, obesity, wound healing; sanitary preparations for medical purposes; dietetic substances adapted for medical use; disinfectants; fungicides; herbicides ] | SECTION 71 - CANCELLED | — |
| 042 | Scientific research within the medical, pharmaceutical and bacteriological area and consultancy and information relating thereto; conducting of tests regarding medical applications in the nature of providing medical testing services in the field of sustained release of pharmaceutical and veterinary drugs; designing and development of medical equipment; designing pharmaceutical and medical preparations in the nature of pharmaceutical drug development services; development of pharmaceutical formulations; design and development of pharmaceutical granulation technology and pharmaceutical tablet technology and consultancy and information relating thereto | ACTIVE | — |
| 045 | [ Licensing of industrial property rights; legal services ] | SECTION 71 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Ascendis Pharma A/S
- Other trademarks owned by Ascendis Pharma A/S
- Other trademarks owned by Ascendis Pharma A/S
- Other trademarks in Class 005
- Other trademarks in Class 042
- Other trademarks in Class 045
- Similar marks named TRANSCON
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Aug 26, 2026 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| Aug 26, 2026 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| Aug 21, 2026 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Aug 20, 2026 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Aug 11, 2026 | EROP | TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED | — |
| Mar 10, 2026 | PR71 | POST REGISTRATION ACTION MAILED - SEC.71 | — |
| Mar 8, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 31, 2025 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Oct 15, 2024 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Mar 10, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Dec 24, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 28, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 21, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Feb 4, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Feb 3, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Jan 15, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 15, 2019 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Aug 23, 2019 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Jul 30, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 30, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 10, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 10, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 10, 2019 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jun 21, 2019 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jun 20, 2019 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jun 20, 2019 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jun 20, 2019 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jun 20, 2019 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 3, 2019 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Apr 17, 2019 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Apr 17, 2019 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 11, 2019 | RCSC | REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED | — |
| Jul 11, 2018 | GNS3 | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | — |
| Jul 11, 2018 | GNSL | LETTER OF SUSPENSION E-MAILED | — |
| Jul 11, 2018 | CNSL | SUSPENSION LETTER WRITTEN | — |
| Jul 11, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 11, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 11, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 11, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jun 21, 2018 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jun 21, 2018 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jun 20, 2018 | ALIE | ASSIGNED TO LIE | — |
| Jun 6, 2018 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 23, 2018 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 23, 2018 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Dec 29, 2017 | RFNT | REFUSAL PROCESSED BY IB | — |
| Dec 8, 2017 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Dec 8, 2017 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Nov 28, 2017 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Nov 26, 2017 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Nov 25, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Nov 22, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Nov 22, 2017 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Nov 16, 2017 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |